News Releases
This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
09 26 2018 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Regional Medical Center Health System (RMC), a regional health care provider for a five-county...
-
09 25 2018 Acquisition to broaden access to tuberculosis (TB) IGRA blood testing in the United StatesQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Oxford Immunotec Global PLC (Nasdaq: OXFD), a global, high-growth diagnostics company, today...
-
09 24 2018 Bolsters Quest's leadership in advanced diagnostics for women's and reproductive healthQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has acquired ReproSource, a national leader in specialty fertility diagnostic...
-
09 07 2018 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Morgan Stanley Global Healthcare...
09 06 2018 - More than half of Americans tested misused their prescription drugs in 2017More than half (52 percent) of Americans tested in 2017 misused their prescription drugs, the same rate as in 2016, but the epidemic is shifting beyond prescription opioids to encompass other...
-
08 17 2018 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.50 per share,...
-
08 16 2018 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it achieved gold status in the American Heart Association's 2018 Workplace...
07 30 2018 - Number of positive tests for Lyme disease increased significantly between 2016 and 2017.The prevalence of Lyme disease is increasing in the United States, spiking significantly between 2016 and 2017, and has spread to all 50 United States and the District of Columbia, according to a...
-
07 24 2018 -- Second quarter revenues of $1.92 billion, up 3.0% from 2017Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the second quarter ended June 30, 2018. "Once...
-
07 17 2018 Third annual study from Quest Diagnostics of health plan executives and physicians suggests physicians need better tools, data access and less complex quality measures to spur adoption2018 QUEST DIAGNOSTICS STUDY FINDS: Physicians and health plan executives agreed healthcare has made little progress toward value-based care since last year – more than two-thirds (67 percent)...
-
07 11 2018 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report second quarter 2018 results on Tuesday, July 24, 2018,...
-
06 25 2018 New AARP Physician Survey Underscores the Need for Innovative Solutions to World's Brain Health Crisis Impacting More Than 50 Million PeopleWASHINGTON, June 25, 2018 -- With nearly 10 million new cases of dementia and Alzheimer's disease occurring each year1, and no cure, today AARP launched a new campaign, "Disrupt Dementia." The...
-
06 23 2018 Late-breaker presentation at the 78th American Diabetes Association Scientific Sessions shows glucose levels and hemoglobin A1c in one third of at risk participants fell to normal levels; more than one-quarter of participants lost five percent or more of body weightEmployer wellness programs that combine laboratory and biometric screening with digital behavioral counseling can significantly reduce employees' risk of developing chronic conditions such as...
-
06 11 2018 Name change coincides with refreshed 2018 product release featuring integrated deep search and other capabilities from Ephesoft to help healthcare organizations improve patient care, drive operational efficiencies and lower costsQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today unveiled the newest version of its Quanum Enterprise Content Management Solution, featuring...
-
06 04 2018 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the William Blair 38th Annual Growth Stock...
-
06 01 2018 Quest Diagnostics participates in new round of fundingBridgewater, NJ – June 1, 2018 Clinical Genomics Technologies Pty Ltd (CG), a leading provider of CRC testing solutions, has completed a $26 million financing. The proceeds from this financing...
-
05 24 2018 - Beginning Jan. 1, 2019, Quest will be participating as a national provider of laboratory services for all UnitedHealthcare plan participantsMINNEAPOLIS and SECAUCUS, N.J., (May 24, 2018) – UnitedHealthcare and Quest Diagnostics (NYSE: DGX) have established a long-term strategic partnership as the two organizations focus on ways to create more personalized care recommendations and a simpler consumer experience for the more than 48 million people enrolled in UnitedHealthcare plans. Quest will be in network for all UnitedHealthcare plan participants beginning Jan. 1, 2019.
-
05 23 2018 - Nearly all physicians (95%) surveyed say they entered primary care to care for the "whole patient," yet 66 percent say they don't have time to address social and behavioral issues that could affect health.The vast majority of primary care physicians don't have the time or tools to adequately address the needs of their patients with multiple chronic conditions, leaving some patients to struggle with...
05 17 2018 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that Helen I. Torley was elected to serve as a director at the company's 2018 Annual...
-
05 14 2018 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.50 per share,...
05 08 2018 Prescription opiate positivity rate drops by double digits, while cocaine rises by double digits in certain statesDriven by increases in cocaine, methamphetamine and marijuana, drug use by the American workforce remains at its highest rate in more than a decade, according to a new analysis released today by...
-
05 07 2018 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it was selected by Forbes as one of America's Best Large Employers...
-
05 04 2018 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Deutsche Bank 43rd Annual Health Care...
-
04 19 2018 - Revenues of $1.88 billion, up 3.7% from 2017Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the first quarter ended March 31, 2018. "We...
04 09 2018 One in four clinicians surveyed will disregard screening guidelines for chlamydia and/or gonorrhea if a patient is asymptomaticDespite record high rates of new cases of sexually transmitted diseases (STDs), young women who are sexually active often don't talk to their clinicians about sex and STD risk, and many aren't...
-
04 06 2018 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report first quarter 2018 results on Thursday, April 19, 2018,...
-
04 02 2018 LOUISVILLE, Ky. & NEW YORK & SECAUCUS, N.J. & MINNETONKA, Minn.--April 2, 2018--Five leading health care organizations – Humana (NYSE: HUM), MultiPlan, Quest Diagnostics (NYSE: DGX) and...
02 26 2018 Collaboration will leverage insights from Quest’s Blueprint for Athletes biometric testing service data to examine physiological changes, performance variables in competitive athletes at the newly created Quest Diagnostics Sports Science Laboratory at the Rutgers–New Brunswick Center for Health & Human PerformanceSecaucus, NJ and New Brunswick, NJ, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, and Rutgers University–New...
-
02 22 2018 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Raymond James 39th Annual Institutional...
-
02 01 2018 Transaction expands Quest’s scale and reach in the mobile provider segment and bolsters its extended care capabilitiesSECAUCUS, N.J. — February 1, 2018 — Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has completed its previously announced...
-
02 01 2018 - Fourth quarter revenues of $1.94 billion, up 4.1% versus 2016Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the fourth quarter and full year ended December...
01 30 2018 Tenth time ChartMaxx honored with top industry ranking*Secaucus, NJ, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, announced today that its ChartMaxx® enterprise...
-
01 23 2018 Acquisition to strengthen Quest's mobile provider capabilities and population health management solutions for health plansQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has formed a definitive agreement to acquire Mobile Medical Examination Service...
-
01 19 2018 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has been named one of the "World's Most Admired Companies" for 2018 by...
-
01 19 2018 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report fourth quarter and full year 2017 results on Thursday,...
-
01 03 2018 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the 36th Annual J.P. Morgan Healthcare...
-
12 12 2017 Transaction broadens access to Quest's diagnostic innovations in the New York-New Jersey metropolitan areaQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has completed its previously announced acquisition of the Shiel Medical...
-
12 11 2017 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced its support for a lawsuit filed by the American Clinical Laboratory Association (ACLA)...
-
12 01 2017 Cleveland HeartLab's Laboratory Facility is Now Quest's National Cardiometabolic Center of Excellence, Serving Physicians and Patients Seeking to Identify and Address Hidden Risks of Heart DiseaseQuest Diagnostics (NYSE: DGX) today announced that it has completed its previously announced acquisition of Cleveland HeartLab. Quest will establish a national center of excellence focused on...
-
11 29 2017 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.45 per share,...
-
11 20 2017 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today provided an update on the impact of the Centers for Medicare and Medicaid Services (CMS)...
-
11 13 2017 At-home collection, one-day fecal immunochemical test that meets American Cancer Society guidelines and HEDIS quality measures for lower gastrointestinal bleeding screening programsBridgewater, N.J., and Secaucus, N.J., Nov. 13, 2017 -- Clinical Genomics, a private company and Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services,...
-
11 01 2017 Five Presentations Show the Clinical Value of Diagnostic Innovations for Assessing Prevalent Autoimmune Diseases, Including Rheumatoid Arthritis and LupusSecaucus, NJ, Nov. 01, 2017 (GLOBE NEWSWIRE) -- Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, announced today that it will present results of...
-
10 30 2017 Transaction Expands Access to Innovative, High-Value Diagnostic Information Services in Southern CaliforniaQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has acquired certain assets of California Laboratory Associates (CLA), a clinical...
-
10 19 2017 - Third quarter revenues of $1.93 billion, up 2.4% versus 2016.Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the third quarter ended September 30, 2017. "We...
-
10 18 2017 - Cleveland HeartLab to be the base for Quest's first national center of excellence in cardiometabolic disorders, with a focus on services that help patients and physicians nationwide identify hidden risks of heart diseaseQuest Diagnostics (NYSE: DGX) today announced it has formed a definitive agreement to acquire Cleveland HeartLab, a leader in innovative diagnostic services for managing cardiovascular disease,...
-
09 29 2017 Quest acquires service businesses of William W. Backus Hospital and The Hospital of Central ConnecticutQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has acquired the outreach lab services operations of two hospitals of Hartford...
-
09 28 2017 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report third quarter 2017 results on Thursday, October 19, 2017,...
-
09 28 2017 Transaction to expand access to Quest's diagnostic innovations in the New York-New Jersey metropolitan areaQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced an agreement under which Quest will acquire the Shiel Medical Laboratory business...
09 28 2017 Analysis of Quest Diagnostics prescription drug monitoring data also found that for more than half of results with concurrent use, one drug had been prescribed by a physician and one had not, suggesting potentially dangerous drug combinations without a physician's oversightMore than 25 percent of patients monitored by lab tests for prescription drug adherence are concurrently taking both opioids and benzodiazepines, according to a new study published online today in...
-
09 27 2017 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that for the third quarter of 2017 it expects a reduction in revenues...
-
09 22 2017 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, responded today to the Centers for Medicare and Medicaid Services (CMS) publication of proposed 2018...
-
09 14 2017 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, was named for the thirteenth consecutive year in the North America Dow Jones Sustainability Index...
-
09 07 2017 Quest is first national diagnostic services provider to use novel LDL-cholesterol calculation that improves accuracy of heart disease screening and helps personalize treatment with lipid-lowering medications such as PCSK9 inhibitors and statinsQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that all of the company's cholesterol test services that involve estimates of...
09 06 2017 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Morgan Stanley Global Healthcare...
09 06 2017 New examination of 3.4 million drug monitoring lab results shows wide evidence of dangerous drug combinations, including opioids/benzodiazepines and heroin/fentanylA majority of test results of patients taking prescription medications show signs of drug misuse, including potentially dangerous drug combinations, finds a new large-scale analysis of laboratory...
-
08 18 2017 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.45 per share,...
-
07 25 2017 - Second quarter revenues of $1.94 billion, up 1.9% on a reported basis and up 2.3% on an equivalent basis versus 2016.Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the second quarter ended June 30, 2017 and raised...
07 19 2017 QHerit Expanded Carrier Screen helps both women and men across multiple ethnicities identify risk of passing 22 genetic diseases to their childrenQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the launch of QHerit™, a new genetic screening service that provides women and men...
-
07 18 2017 Quest Diagnostics (NYSE: DGX) today announced that it has completed its previously announced acquisition of the laboratory businesses Med Fusion and Clear Point. Operating from a nearly 200,000...
-
07 06 2017 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report second quarter 2017 results on Tuesday, July 25, 2017,...
-
06 27 2017 Acquisition to Enhance Access to Innovative, High-value Diagnostic Information Services for People on Cape CodQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has signed a nonbinding letter of intent to acquire the outreach laboratory...
-
06 26 2017 MADISON, N.J. and BENTONVILLE, Ark., June 26, 2017-- Quest Diagnostics (NYSE: DGX) and Wal-Mart Stores, Inc. (NYSE: WMT), announced they will be working together to help improve access to care...
06 22 2017 Quest Diagnostics Adds Custom Coaching, At-Home Collection to Expand Blueprint for Athletes™ ServiceFitness enthusiasts can customize biometric testing service to fit their lifestyle with redesigned packages, one-on-one coaching and goal setting as well as at-home phlebotomy and microsamplingFitness devotees and amateur and competitive athletes can now access sports biomarker testing from their home with a suite of expanded capabilities from Blueprint for Athletes, the biomarker...
-
06 12 2017 - Quest to acquire Lewisville, Texas-based Med Fusion and Clear Point to create a base in the southwestern United States for providing precision medicine diagnostics to aid cancer treatment and careQuest Diagnostics (NYSE: DGX) today announced that it has signed definitive agreements to acquire two laboratory businesses in Lewisville, Texas, with the aim to establish a center of excellence...
-
06 08 2017 Healthcare analytics technology from Quest Diagnostics and Inovalon extends value of electronic health records to close patient gaps in real timeQuest Diagnostics (NYSE: DGX) and Inovalon (NASDAQ: INOV) announced that their point-of-care health analytics technology Data Diagnostics® won a MedTech Breakthrough Award for Best Overall...
-
06 06 2017 Health plan executives say co-investment in HIT with providers may bridge remaining gaps and accelerate value-based care adoption2017 QUEST DIAGNOSTICS/INOVALON STUDY FINDS: Tools still lacking to support value-based care: Fifty-three percent of health plan executives said physicians have the tools they need, but only 43...
-
05 16 2017 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.45 per share,...
05 16 2017 Cocaine, marijuana and methamphetamine use up broadly among United States workforce across multiple specimen types and testing populationsDrug use in the American workforce, fueled by illicit drugs, reached the highest positivity rate in 12 years, according to an analysis of more than ten million workforce drug test results released...
-
05 12 2017 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the UBS Global Healthcare Conference in New...
-
05 02 2017 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Deutsche Bank 42nd Annual Health Care...
-
05 01 2017 Quest completes acquisition of PeaceHealth Laboratories' outreach lab services operationQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and PeaceHealth, a mission-based not-for-profit healthcare system, today announced that they have...
05 01 2017 Award recognizes the innovation of the QuestQuanum™ portfolio of data analytics and information technology solutionsQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its senior vice president and chief information officer Lidia L. Fonseca has...
-
04 24 2017 Healthcare analytics technology from Quest Diagnostics and Inovalon enables patient data to be turned into actionable insights that inform quality, reimbursement and care outcomesQuest Diagnostics (NYSE: DGX) and Inovalon (NASDAQ: INOV) announced that Data Diagnostics®, a point-of-care health analytics technology, won a gold award in the Health and Wellness—Patient Care...
-
04 24 2017 To mark the milestone, Quest provides charitable grants of $50,000 each to the American Red Cross, the National Ovarian Cancer Coalition and Autism SpeaksQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, commemorated its 50-year anniversary by awarding $150,000 in total grants to three organizations...
-
04 20 2017 - First quarter revenues of $1.90 billion, up 1.9% on a reported basis and up 3.0% on an equivalent basis versus 2016Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the first quarter ended March 31, 2017 and raised...
04 07 2017 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report first quarter 2017 results on Thursday, April 20, 2017,...
04 06 2017 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today awarded Supplier Excellence Awards to five companies at its 2017 Supplier Forum. Supplier...
03 07 2017 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Barclays Global Healthcare Conference in...
03 06 2017 Quest Diagnostics will donate up to $200,000 to American Diabetes Association -- $1 for every employee biometric wellness screening it completes between March 28 and April 27Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, including employer health and wellness screening and health improvement services, announced a unique...
02 21 2017 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.45 per share,...
02 16 2017 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has been named one of the "World's Most Admired Companies" for 2017 by...
02 16 2017 Quest Diagnostics: Harvard Pilgrim Health Care Partners with Physicians to Close Costly Gaps in CarePhysicians to use health analytics technology Data Diagnostics® from Quest Diagnostics and Inovalon to help improve patient care and financial performanceHarvard Pilgrim Health Care now offers physicians Data Diagnostics®, a point-of-care health analytics technology from Quest Diagnostics (NYSE: DGX) and Inovalon (NASDAQ: INOV) that is designed to...
02 15 2017 Quest to acquire PeaceHealth Laboratories' outreach lab services and assume management of labs located within PeaceHealth's medical centers in three statesQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and PeaceHealth, a mission-based not-for-profit healthcare system, have formed a two-part...
-
02 08 2017 Veracyte, Inc. (NASDAQ: VCYT), a genomic diagnostics company focused on reducing unnecessary surgeries and healthcare costs by resolving diagnostic uncertainty, will extend access to its Afirma...
01 26 2017 -- Fourth quarter revenues of $1.86 billion, up 0.7% on a reported basis and up 1.9% on an equivalent basis versus 2015Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the fourth quarter and full year ended December...
01 26 2017 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, is working with Montefiore Health System (MHS) to provide diagnostic laboratory services. This...
01 18 2017 Company expands hepatitis testing capabilities with new HBV surface antigen (sAg) quantitative testingQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the launch of a new test service that helps physicians evaluate a patient's response...
01 11 2017 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report fourth quarter and full year 2016 results on Thursday,...
01 06 2017 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, received a rating of 100 from the Human Rights Campaign Foundation on the 2017...
01 05 2017 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the 35th Annual J.P. Morgan Healthcare...
12 15 2016 Daniel C. Stanzione Named Lead Independent DirectorQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostics information services, today announced that its Board of Directors elected Stephen H. Rusckowski, the company's President...
12 12 2016 Quest Diagnostics Incorporated (NYSE: DGX) announced today that it is investigating an unauthorized third-party intrusion into an internet application on its network. The company provided notice...
12 07 2016 Point-of-care healthcare analytics technology from Quest Diagnostics and Inovalon facilitates better care quality and value-based financial performanceQuest Diagnostics (NYSE: DGX) and Inovalon (NASDAQ: INOV) today announced that Data Diagnostics™, a point-of-care healthcare analytics technology, has been named the Most Innovative Product of...
11 21 2016 Service provides patients autonomy over their own health by allowing them to choose from diagnostic tests without a physician's orderQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, has launched QuestDirect, a new Patient-Initiated Testing service which will empower consumers who...
11 11 2016 - Revenue growth beyond 2016 to be between 3-5%, earnings to grow faster than revenues in mid-to-high single digit rangeAt a meeting with analysts and investors at its Investor Day today, members of the senior management team of Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic...
10 20 2016 - Revenues of $1.89 billion, up 0.3% on a reported basis and up 2.1% on an equivalent basis versus 2015Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that for the third quarter ended September 30, 2016, reported net...
-
10 18 2016 Memorial Sloan Kettering Cancer Center to Provide Deep Knowledge Base to Augment Watson’s Data Sources and Quest’s Medical Reporting New Service Extends Reach to Community Oncologists Who Provide 70 Percent of Cancer CareCAMBRIDGE, MA, MADISON, NJ, and NEW YORK, NY - 18 Oct 2016: IBM Watson Health (NYSE: IBM) and Quest Diagnostics (NYSE: DGX) today announced the launch of IBM Watson Genomics from Quest...
-
10 06 2016 The Healthcare Businesswomen's Association (HBA) has named Quest Diagnostics' Women in Leadership (WIL) Employee Business Network as the winner of the 2016 HBA ACE award. ACE (Advancement,...
10 06 2016 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report third quarter 2016 results on Thursday, October 20, 2016,...
